Literature DB >> 30239639

Pulmonary diffusion capacity predicts major complications after esophagectomy for patients with esophageal cancer.

L Goense1,2, J Meziani1, M Bülbül3, S A Braithwaite4, R van Hillegersberg1, J P Ruurda1.   

Abstract

A reduced forced expiratory volume in one second (FEV1) is a well-recognized risk factor for complications after esophagectomy. Lung diffusing capacity for carbon monoxide (DLCO) is not routinely integrated in the risk assessment of esophagectomy. The aim of this study is to evaluate the association of preoperative pulmonary function tests with major postoperative complications after esophagectomy for cancer. In order to achieve this aim, 459 patients with newly diagnosed esophageal cancer who underwent elective transthoracic (n = 352) or transhiatal (n = 107) surgical resection of the esophagus with cervical anastomosis between 2003 and 2015 were analyzed. Multivariable logistic regression analysis was performed to assess the association of preoperative pulmonary function tests (expressed as % of predicted) with major complications after esophagectomy, adjusted for previously identified predictors. Major complications were defined as Clavien-Dindo grade IIIb or higher. Of the 459 included patients, 114 (24.8%) developed major complications. In univariable analysis FEV1, forced vital capacity (FVC), vital capacity (VC), and DLCO were associated with major complications. After adjusting each pulmonary function test for age, American Society of Anesthesiologists (ASA) score, cardiac comorbidity, diabetes mellitus, peripheral vascular disease, and surgical approach, FVC (OR: 1.24 per 10% decrease; 95% CI: 1.06-1.45; P = 0.004), VC (OR: 1.19 per 10% decrease; 95% CI: 1.02-1.39; P = 0.025) and DLCO (OR: 1.16 per 10% decrease; 95%CI: 1.02-1.33; P = 0.025) remained predictive factors for major surgical complications. In multivariable analysis in which all pulmonary functions tests were combined, DLCO was the strongest predictor of major complications (OR: 1.14 per 10% increase; 95% CI: 1.01-1.30; P = 0.046). The ideal cut-off for DLCO% of predicted was determined at <84% (OR: 1.97; 95% CI: 1.28-3.03; P = 0.002). These data indicate that DLCO is an independent predictor of major complications after esophagectomy for cancer. This pulmonary function test deserves greater consideration in prediction research of major complications after esophagectomy.
© The Author(s) 2018. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus.

Entities:  

Keywords:  DLCO; diffusing capacity; esophageal cancer; esophagectomy; pulmonary function tests; surgical complications TLCO

Mesh:

Year:  2019        PMID: 30239639     DOI: 10.1093/dote/doy082

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  Development and validation of a novel nomogram for postoperative pulmonary complications following minimally invasive esophageal cancer surgery.

Authors:  Chaoyang Tong; Yuan Liu; Jingxiang Wu
Journal:  Updates Surg       Date:  2021-10-24

2.  Predictive model of postoperative pneumonia after neoadjuvant immunochemotherapy for esophageal cancer.

Authors:  Wei Wang; Yongkui Yu; Haibo Sun; Zongfei Wang; Yan Zheng; Guanghui Liang; Peinan Chen; Jiwei Cheng; Xiaoxia Xu; Funa Yang; Qi Liu; Weiqun Xing
Journal:  J Gastrointest Oncol       Date:  2022-04

3.  Epidural analgesia and avoidance of blood transfusion are associated with reduced mortality in patients with postoperative pulmonary complications following thoracotomic esophagectomy: a retrospective cohort study of 335 patients.

Authors:  Kai B Kaufmann; Wolfgang Baar; Torben Glatz; Jens Hoeppner; Hartmut Buerkle; Ulrich Goebel; Sebastian Heinrich
Journal:  BMC Anesthesiol       Date:  2019-08-22       Impact factor: 2.217

4.  Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.

Authors:  F Klevebro; J A Elliott; A Slaman; B D Vermeulen; S Kamiya; C Rosman; S S Gisbertz; P R Boshier; J V Reynolds; I Rouvelas; G B Hanna; M I van Berge Henegouwen; S R Markar
Journal:  Ann Surg Oncol       Date:  2019-06-10       Impact factor: 5.344

5.  Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma.

Authors:  Shou-Jia Hu; Xue-Ke Zhao; Xin Song; Ling-Ling Lei; Wen-Li Han; Rui-Hua Xu; Ran Wang; Fu-You Zhou; Liang Wang; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2021-01-28       Impact factor: 5.742

6.  Comparison of a modified one-piece mechanical and double-layer hand-sewn anastomosis in McKeown esophagogastrectomy: A single-institute retrospective study.

Authors:  Kunshou Zhu; Jiulong Zhang; Xiaohui Chen; Yujie Deng; Shaofeng Lin; Yibin Cai; Guibin Weng
Journal:  Mol Clin Oncol       Date:  2021-05-12

7.  Impairment of Lung Function Increases the Risk of Postoperative Respiratory Failure for Esophageal Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Yanming Sun; Ying Zhu
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

Review 8.  Physiotherapy Regimens in Esophagectomy and Gastrectomy: a Systematic Review and Meta-Analysis.

Authors:  Karina H Tukanova; Swathikan Chidambaram; Nadia Guidozzi; George B Hanna; Alison H McGregor; Sheraz R Markar
Journal:  Ann Surg Oncol       Date:  2021-12-27       Impact factor: 5.344

9.  Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy.

Authors:  Steven H Lin; Kaiping Liao; Xiudong Lei; Vivek Verma; Sherif Shaaban; Percy Lee; Aileen B Chen; Albert C Koong; Wayne L Hoftstetter; Steven J Frank; Zhongxing Liao; Ya-Chen Tina Shih; Sharon H Giordano; Grace L Smith
Journal:  Int J Part Ther       Date:  2022-06-23

10.  Risk Factors of Cervical Anastomotic Leakage after McKeown Minimally Invasive Esophagectomy: Focus on Preoperative and Intraoperative Lung Function.

Authors:  Wenda Gao; Mingbo Wang; Peng Su; Fan Zhang; Chao Huang; Ziqiang Tian
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-10-20       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.